Publications by authors named "Deepa Sugumar"

Claim this Profile
P
Protective role of harmol against β-cell toxicity and glucose dysregulation in type 2 diabetes mellitus.
Deepa Sugumar, Emdormi Rymbai, Ram Kothandan, Amritha Chakkittukandiyil, Praveen Thaggikuppe Krishnamurthy

Eur J Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2/ARE pathway in Parkinson's disease.
Amritha Chakkittukandiyil, Deepak Vasudevan Sajini, Emdormi Rymbai, Deepa Sugumar, Jinu Mathew

Toxicol Appl Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligandrol Ameliorates High-Fat Diet- and Streptozotocin-Induced Type 2 Diabetes Mellitus and Prevents Pancreatic Islets Degeneration.
Deepa Sugumar, Ritaban Ghosh, Emdormi Rymbai, Jaikanth Chandrasekaran, Praveen Thaggikuppe Krishnamurthy

Assay Drug Dev Technol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Side effects based network construction and drug repositioning of ropinirole as a potential molecule for Alzheimer's disease: an , , and study.
Amritha Chakkittukandiyil, Saurav Chakraborty, Ram Kothandan, Emdormi Rymbai, Santhosh Kumar Muthu, Deepa Sugumar

J Biomol Struct Dyn· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases.
Emdormi Rymbai, Deepa Sugumar, Amritha Chakkittukandiyil, Ram Kothandan, Divakar Selvaraj

Cell Biochem Funct· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson's disease models.
Emdormi Rymbai, Deepa Sugumar, Amritha Chakkittukandiyil, Ram Kothandan, Jubie Selvaraj

Life Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preliminary study to identify existing drugs for potential repurposing in breast cancer based on side effect profile.
Emdormi Rymbai, Deepa Sugumar, Praveen Thaggikuppe Krishnamurthy, Divakar Selvaraj, Soumya Vasu

Drug Res (Stuttg)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of anti-inflammatory and anti-arthritic property of ethanolic extract of .
K P Swathi, Saravanan Jayaram, Deepa Sugumar, Emdormi Rymbai

Chin Herb Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ropinirole, a potential drug for systematic repositioning based on side effect profile for management and treatment of breast cancer.
Emdormi Rymbai, Deepa Sugumar, J Saravanan, S Divakar

Med Hypotheses· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis